Invicta Diagnostic Limited (NSE: INVICTA), ISIN INE0XJ501010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INVICTA last traded at ₹66.75 (+1.14%), with a 52-week range of ₹58.10 to ₹105.00 (as of 29 Jul 2026).
Shareholding as of Mar 2026: promoters 66.70%, FIIs 4.20%, DIIs 4.30%, mutual funds 0.00%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.